Part A: RPL554

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

2 competitors in Pulmonary Disease, Chronic Obstructive

Drug Information

Target Indication

Pulmonary Disease, Chronic Obstructive

Clinical Trial

Last updated: 12/13/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

VRNA

VERONA PHARMA

Related Pipeline

Chronic Obstructive Pulmonary Disease

COPD

Non-cystic Fibrosis Bronchiectasis

COPD

Chronic Obstructive Pulmonary Disease